ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2021
Canadian Urological Association guideline on testosterone deficiency in men: Evidence-based Q&A.
Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it, 17 citations in OpenAlex.
- Care of Patients with Male Hypogonadism: A Joint Position Statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), the Brazilian Society of Urology (SBU), and the Brazilian Association for Sexual Medicine and Health (ABEMSS).International braz j urol : official journal of the Brazilian Society of UrologyGuideline
- Review
- The Evidence-Practice Gap in Testosterone Therapy for Prostate Cancer: A Narrative Review.Cureus · 2026Review
- Male Hypogonadism: The Korean Society of Men's Health and Aging Position Statement.The world journal of men's health · 2025Review
- Assessing the methodologic heterogeneity of Canadian Urological Association guidelines Adoption of the GRADE approach (2018-2023).Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025Article
- Testosterone supplementation for men.Canadian family physician Medecin de famille canadien · 2025Article
- Testosterone therapy at the time of vasectomy reversal Impact on intraoperative decision-making and interpretation of postoperative outcomes.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024Article
- Atlas of 35 patient reported outcome measures (PROMs) in andrology: a comprehensive overview of literature.World journal of urology · 2023Review
- Major adverse cardiovascular events associated with testosterone treatment: a pharmacovigilance study of the FAERS database.Frontiers in pharmacology · 2023Article
- Testosterone therapy and secondary erythrocytosis.International journal of impotence research · 2022Review
- Testicular cancer survivorship: Long-term toxicity and management.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022Review
- Secondary Polycythemia in Men Receiving Testosterone Therapy Increases Risk of Major Adverse Cardiovascular Events and Venous Thromboembolism in the First Year of Therapy.The Journal of urology · 2022Article
- An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting.International journal of general medicine · 2022Review
- Canadian Urological Association guideline: Erectile dysfunction.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 8 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.